Compare TG Therapeutics Inc (TGTX) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Vale SA — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Vale SA trades at $14.13 (market cap $59.07B). The key difference: Vale SA is far larger — about 7.2× TG Therapeutics Inc's market cap, and Vale SA pays a 8.93% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VALE | |
|---|---|---|
Market Cap | $8.26B | $59.07B |
Sector | Health | Basic Materials |
52-Week High | $59.06 | $17.82 |
52-Week Low | $26.39 | $9.53 |
Enterprise Value | $8.50B | $75.99B |
Dividend Yield | — | 8.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
